FRAZIER MANAGEMENT LLC - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 19 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2020$408,000
-60.6%
199,953
-42.9%
0.04%
-59.3%
Q2 2020$1,036,000
-62.7%
349,953
-66.7%
0.09%
-71.1%
Q1 2020$2,775,000
-58.6%
1,049,953
-22.2%
0.32%
-72.0%
Q4 2019$6,709,000
-16.6%
1,349,9530.0%1.12%
-55.3%
Q3 2019$8,046,000
-7.6%
1,349,9530.0%2.52%
+12.8%
Q2 2019$8,707,000
-4.5%
1,349,9530.0%2.23%
+1.6%
Q1 2019$9,119,000
+66.0%
1,349,9530.0%2.20%
+54.8%
Q4 2018$5,494,000
-62.6%
1,349,9530.0%1.42%
-47.3%
Q3 2018$14,687,0001,349,9532.69%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q4 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,349,953$8,046,0002.52%
Novo Holdings A/S 2,181,843$13,004,0002.23%
Sofinnova Investments, Inc. 1,180,178$7,034,0000.64%
TPG Group Holdings (SBS) Advisors, Inc. 2,041,496$12,168,0000.09%
Eventide Asset Management 392,513$2,288,0000.08%
Blackstone Inc. 1,623,405$9,675,0000.06%
Granahan Investment Management 141,012$840,0000.05%
Janney Montgomery Scott LLC 46,861$279,0000.00%
BANK OF MONTREAL /CAN/ 5,921$35,0000.00%
BlackRock Inc. 15,755$94,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders